Prescription medication · Calcium Channel Blocker / ACE Inhibitor Combination
amlodipine/benazepril
Also sold as Lotrel. Lotrel is used to treat high blood pressure.
Data updated 2026-05-15
- 112,713
- FDA reports
- 7
- InteractionsFew interactions
- $12.23
- Brand price (NADAC)
What the data shows
amlodipine/benazepril (Lotrel) is a prescription Calcium Channel Blocker / ACE Inhibitor Combination, with 112,713 FDA adverse-event reports on file, with 7 documented drug interactions.
Reporting volume reflects how widely a drug is used and studied, not how dangerous it is, a FAERS report documents a temporal association, never proof of cause.
amlodipine/benazepril (Lotrel) is a prescription Calcium Channel Blocker / ACE Inhibitor Combination. Lotrel is used to treat high blood pressure.
Lotrel is a combination medicine that contains amlodipine and benazepril. It is used to treat high blood pressure.
Verify with FDA → · CMS NADAC pricing →
Drug Pricing (NADAC)
Brand Price
$12.23/unit
Generic Available
No
Pricing data from NADAC (CMS), effective December 18, 2024. Compare all drug costs →
What it does
Lotrel is used to treat high blood pressure.
Common side effects
Cough, Headache, Dizziness
Key warnings
This medicine can harm your unborn baby or cause death.
The sections below are summarized in plain English from amlodipine/benazepril's FDA-approved prescribing information. They describe what the official label says, and are not personal medical advice.
How It Works
Lotrel contains two medicines that work in different ways to lower blood pressure. Amlodipine relaxes and widens blood vessels so blood can flow more easily. Benazepril lowers blood pressure by preventing your body from making a substance that narrows blood vessels.
Side Effects (from patient reports)
Based on 112,713 FDA adverse event reports.
Most-reported reactions
Adverse reactions in FAERS for amlodipine/benazepril, by number of reports
- Tiredness
Tiredness
15,696 reports
- Diarrhea
Diarrhea
14,038 reports
- Feeling sick to your stomach
Feeling sick to your stomach
13,425 reports
- Shortness of breath
Shortness of breath
13,222 reports
- Feeling lightheaded
Feeling lightheaded
10,671 reports
- Head pain
Head pain
9,887 reports
- Sudden kidney damage
Sudden kidney damage
9,369 reports
- Discomfort
Discomfort
9,175 reports
- Throwing up
Throwing up
8,736 reports
- Accidental fall
Accidental fall
8,494 reports
What this shows Bars show how often each reaction was reported, not how likely it is to happen, a report records a temporal association, never proof that the drug caused it.
Serious Warnings
This medicine can harm your unborn baby or cause death. If you become pregnant, stop taking Lotrel and tell your doctor right away.
Known Drug Interactions
7 DRUG INTERACTIONS • Potassium supplements/potassium-sparing diuretics: hyperkalemia ( 7.1 ) • Lithium: Increased serum lithium levels; toxicity symptoms ( 7.1 ) • Injectable gold: facial flushing, nausea, vomiting, hypotension ( 7.1 ) • Nonsteroidal Anti-Inflammatory Drugs (NSAIDs): Risk of renal dysfunction, loss of antihypertensive effect ( 7.1 ) • Do not exceed doses greater than 20 mg daily of simvastatin ( 7.1 ) • mTOR inhibitors: increased risk of angioedema ( 7.1 ) • Dual inhibition of the RAS: Increased risk of renal impairment, hypotension, and hyperkalemia ( 7.1 ) • Neprilysin...
Mechanism: This combination pill already contains amlodipine, so taking extra amlodipine separately can lead to an overdose and dangerously low blood pressure.
7 DRUG INTERACTIONS • Potassium supplements/potassium-sparing diuretics: hyperkalemia ( 7.1 ) • Lithium: Increased serum lithium levels; toxicity symptoms ( 7.1 ) • Injectable gold: facial flushing, nausea, vomiting, hypotension ( 7.1 ) • Nonsteroidal Anti-Inflammatory Drugs (NSAIDs): Risk of renal dysfunction, loss of antihypertensive effect ( 7.1 ) • Do not exceed doses greater than 20 mg daily of simvastatin ( 7.1 ) • mTOR inhibitors: increased risk of angioedema ( 7.1 ) • Dual inhibition of the RAS: Increased risk of renal impairment, hypotension, and hyperkalemia ( 7.1 ) • Neprilysin...
Mechanism: The amlodipine in this combination pill increases the amount of simvastatin that stays in your bloodstream.
7 DRUG INTERACTIONS • Potassium supplements/potassium-sparing diuretics: hyperkalemia ( 7.1 ) • Lithium: Increased serum lithium levels; toxicity symptoms ( 7.1 ) • Injectable gold: facial flushing, nausea, vomiting, hypotension ( 7.1 ) • Nonsteroidal Anti-Inflammatory Drugs (NSAIDs): Risk of renal dysfunction, loss of antihypertensive effect ( 7.1 ) • Do not exceed doses greater than 20 mg daily of simvastatin ( 7.1 ) • mTOR inhibitors: increased risk of angioedema ( 7.1 ) • Dual inhibition of the RAS: Increased risk of renal impairment, hypotension, and hyperkalemia ( 7.1 ) • Neprilysin...
Mechanism: Benazepril can make it harder for the kidneys to remove lithium from the body, causing lithium levels to rise. This increase can lead to lithium poisoning or other serious side effects.
Dual Blockade of the Renin-Angiotensin System (RAS): Dual blockade of the RAS with angiotensin receptor blockers, ACE inhibitors, or aliskiren is associated with increased risks of hypotension, hyperkalemia, and changes in renal function (including acute renal failure) compared to monotherapy. Do not coadminister aliskiren with Lotrel in patients with diabetes. Avoid use of aliskiren with Lotrel in patients with renal impairment [glomerular filtration rate (GFR) < 60 mL/min].
Mechanism: Both of these drugs target the same system that controls blood pressure, which can cause your blood pressure to drop too low. This combination also increases the risk of kidney damage and high potassium levels.
Potassium-sparing diuretics (spironolactone, amiloride, triamterene, and others) or potassium supplements can increase the risk of hyperkalemia. Potassium-sparing diuretics (spironolactone, amiloride, triamterene, and others) or potassium supplements can increase the risk of hyperkalemia.
Mechanism: Both of these medications can cause your body to hold onto potassium instead of flushing it out. This can lead to dangerously high levels of potassium in your blood.
This is a plain-language summary of FDA-label interaction records and does not provide individual medication-combination directions.
Common Questions
What should I avoid while taking Lotrel?
Can I take Lotrel if I have kidney problems?
How long does it take for Lotrel to work?
What if I experience swelling while taking this medicine?
Can I drink alcohol while taking Lotrel?
Will this medicine cure my high blood pressure?
Can I stop taking Lotrel if my blood pressure is normal?
Can I take other medicines with Lotrel?
What are the symptoms of low blood pressure?
What are the common side effects of amlodipine/benazepril?
Does amlodipine/benazepril interact with other medications?
What drug class is amlodipine/benazepril?
What pregnancy or breastfeeding source fields are listed for amlodipine/benazepril?
Related Medications in Calcium Channel Blocker / ACE Inhibitor Combination
Other drugs grouped near amlodipine/benazepril - same-class peers and common alternatives.
acebutolol
Sectral
Acebutolol is a medicine that helps lower blood pressure and control irregular heartbeats.
Compare with amlodipine/benazepril →
aliskiren
Tekturna
Tekturna is a medicine used to treat high blood pressure.
Compare with amlodipine/benazepril →
amiloride
Midamor
Amiloride is a water pill that helps your body hold onto potassium.
Compare with amlodipine/benazepril →
amlodipine
Norvasc
Amlodipine (Norvasc) is a drug that lowers blood pressure and treats chest pain.
Compare with amlodipine/benazepril →
amlodipine/valsartan
Exforge
Exforge HCT is a combination medicine used to treat high blood pressure.
Compare with amlodipine/benazepril →
Medication Guides
Understanding Drug Interactions
How CYP450 enzymes, inhibitors, and inducers affect your medications
Generic vs Brand Name Drugs
FDA requirements, cost savings, and when the difference matters
Narrow Therapeutic Index Drugs
FDA bioequivalence and label-record context for narrow therapeutic index medicines
Common Drug Interactions
Dangerous medication combinations and how to protect yourself
Save on amlodipine/benazepril
Compare prices and find discounts at pharmacies near you. Free coupons can save up to 80% on prescriptions.
Disclosure: This link may earn us a commission at no extra cost to you. See our terms.
What the FDA Data Shows for amlodipine/benazepril
The FDA label for amlodipine/benazepril (sold under brand names such as Lotrel) classifies it as a prescription-only medication in the Calcium Channel Blocker / ACE Inhibitor Combination class. Lotrel is used to treat high blood pressure. Official labeling lists 4 commonly reported side effects, including Cough, Headache, Dizziness.
Post-market surveillance from the FDA Adverse Event Reporting System (FAERS) captures real-world experience. For this drug, FAERS contains 112,713 voluntary reports. The database also lists 7 documented drug interactions derived from FDA labeling, with the top-flagged interaction rated major severity. NADAC pricing from CMS.
Report counts do not establish causation, a FAERS entry documents a temporal association, not proof that the drug produced the outcome. Widely prescribed medications naturally accumulate more reports than niche therapies, so raw totals must be interpreted alongside total exposure. Shortage status, recall history, and patent information are separate source-record fields. This page is a public FDA/CMS registry and does not provide medical, treatment, substitution, or medication-change directions.
Data Sources
Drug labeling: FDA Drug Labels (SPL/DailyMed). Adverse events: FDA Adverse Event Reporting System (FAERS). Pricing: CMS National Average Drug Acquisition Cost (NADAC).
FAERS reports are voluntary and do not establish causation. Drug interactions are derived from FDA labeling and clinical references. This registry does not provide medication decisions.
Last updated: August 1, 2023
PlainMeds is rendered directly from FDA openFDA/FAERS extracts, DailyMed labels, and CMS drug-pricing files, no number is typed in by an editor. FAERS counts, recalls, shortages, and price figures on this page are queried live from those federal extracts. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-05-15. Primary sources: openFDA / FAERS, DailyMed and CMS Part B ASP.
Read our methodology - how this data is sourced, computed, and verified.
Data currency: FDA FAERS adverse-event reports through 2025, CMS NADAC acquisition-cost pricing effective December 2024, compiled from the source snapshot dated . See our methodology for per-source dates and refresh cadence. Spot a figure that looks wrong? Report a data issue.
All federal data sources used on this page
- FDA Orange Book - approved drug products with therapeutic equivalence. accessdata.fda.gov/cder/ob
- FDA DailyMed - NIH-hosted drug labeling for FDA-approved meds. dailymed.nlm.nih.gov
- FDA Adverse Event Reporting System (FAERS) - post-marketing safety surveillance. fda.gov/drugs/faers
- NLM RxNorm - standardized clinical drug nomenclature. nlm.nih.gov/research/umls/rxnorm
- CMS Medicare Part B Drug Average Sales Price Files - federal drug pricing data. cms.gov/medicare/part-b-drugs/asp
- FDA Drug Shortages Database - current and resolved drug shortage tracking. accessdata.fda.gov/drugshortages